Skip to main content
Top
Published in: Clinical and Molecular Allergy 1/2012

Open Access 01-12-2012 | Case Report

Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome)

Authors: Naouel Guirat-Dhouib, Yemen Baccar, Imène Ben Mustapha, Monia Ouederni, Sameh Chouaibi, Nadia El Fekih, Mohamed Ridha Barbouche, Bassima Fezaa, Ridha Kouki, Slama Hmida, Fethi Mellouli, Mohamed Bejaoui

Published in: Clinical and Molecular Allergy | Issue 1/2012

Login to get access

Abstract

Background

Major histocompatibility complex class II deficiency, also referred to as bare lymphocyte syndrome is a rare primary Immunodeficiency disorder characterized by a profondly deficient human leukocyte antigen class II expression and a lack of cellular and humoral immune responses to foreign antigens. Clinical manifestations include extreme susceptibility to viral, bacterial, and fungal infections. The infections begin in the first year of life and involve usually the respiratory system and the gastrointestinal tract. Severe malabsorption with failure to thrive ensues, often leading to death in early childhood. Bone marrow transplantation is the curative treatment.

Case reports

Here we report two cases with a late outcome MHC class II deficiency. They had a long term history of recurrent bronchopulmonary and gastrointestinal infections. Bone marrow transplantation could not be performed because no compatible donor had been identified. At the age of 12 years, they developed oral papillomatous lesions related to HPV (human papillomavirus). The diagnosis of HPV infection was done by histological examination. HPV typing performed on the tissue obtained at biopsy showed HPV type 6. The lesions were partially removed after two months of laser treatment.

Conclusions

Viral infections are common in patients with MHC class II and remain the main cause of death. Besides warts caused by HPV infection do not exhibit a propensity for malignant transformation; they can cause great psychosocial morbidity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siepermann M, Gudowius S, Beltz K, Strier U, Feyen O, Troeger A, Gçbel U, Laws HJ, Kçgler G, Meisel R, Dilloo D, Niehues T: MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature. Pediatr Transplantation. 2011, 15: E80-E86. 10.1111/j.1399-3046.2010.01292.x.CrossRef Siepermann M, Gudowius S, Beltz K, Strier U, Feyen O, Troeger A, Gçbel U, Laws HJ, Kçgler G, Meisel R, Dilloo D, Niehues T: MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature. Pediatr Transplantation. 2011, 15: E80-E86. 10.1111/j.1399-3046.2010.01292.x.CrossRef
2.
go back to reference Reith W, Lisowska-Grospierre B, Fischer A: Molecular basis of major histocompatibility complex class II deficiency. Primary immunodeficiency diseases. Edited by: Ochs HD, Smith CI, Puck JM. New York: Oxford University Press 2007, 227-241. Reith W, Lisowska-Grospierre B, Fischer A: Molecular basis of major histocompatibility complex class II deficiency. Primary immunodeficiency diseases. Edited by: Ochs HD, Smith CI, Puck JM. New York: Oxford University Press 2007, 227-241.
3.
go back to reference Wiszniewski W, Fondaneche MC, Lambert N, Masternak K, Picard C, Notarangelo L, Schwartz K, Bal J, Reith W, Alcaide C, De Saint Basile G, Fischer A, Lisowska-Grospierre B: Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics. 2000, 51: 261-267. 10.1007/s002510050619CrossRefPubMed Wiszniewski W, Fondaneche MC, Lambert N, Masternak K, Picard C, Notarangelo L, Schwartz K, Bal J, Reith W, Alcaide C, De Saint Basile G, Fischer A, Lisowska-Grospierre B: Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B. Immunogenetics. 2000, 51: 261-267. 10.1007/s002510050619CrossRefPubMed
4.
go back to reference Picard C, Fischer A: Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency. Immunol Allergy Clin N Am. 2010, 30: 173-178. 10.1016/j.iac.2010.01.001.CrossRef Picard C, Fischer A: Hematopoietic stem cell transplantation and other management strategies for MHC class II deficiency. Immunol Allergy Clin N Am. 2010, 30: 173-178. 10.1016/j.iac.2010.01.001.CrossRef
5.
go back to reference Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression of MHC class U genes. Immunodef Rev. 1989, 1: 135-153.PubMed Griscelli C, Lisowska-Grospierre B, Mach B: Combined immunodeficiency with defective expression of MHC class U genes. Immunodef Rev. 1989, 1: 135-153.PubMed
6.
go back to reference Villard J, Masternak K, Lisowska-Grospierre B, Fischer A, Reith W: MHC class II deficiency: a disease of gene regulation. Medicine. 2001, 80: 405-418. 10.1097/00005792-200111000-00006CrossRefPubMed Villard J, Masternak K, Lisowska-Grospierre B, Fischer A, Reith W: MHC class II deficiency: a disease of gene regulation. Medicine. 2001, 80: 405-418. 10.1097/00005792-200111000-00006CrossRefPubMed
7.
go back to reference Klein C, Lisowska-Grospierre B, Ledeist F, Fischer A, Griscelli C: Major histocompatibility complex class II deficiency: clinical manifestations, immunological features and outcome. J Pediatr. 1993, 123: 921-928. 10.1016/S0022-3476(05)80388-9CrossRefPubMed Klein C, Lisowska-Grospierre B, Ledeist F, Fischer A, Griscelli C: Major histocompatibility complex class II deficiency: clinical manifestations, immunological features and outcome. J Pediatr. 1993, 123: 921-928. 10.1016/S0022-3476(05)80388-9CrossRefPubMed
8.
go back to reference Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A: Long-term survival and transplantationof haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003, 361: 553-560. 10.1016/S0140-6736(03)12513-5CrossRefPubMed Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A: Long-term survival and transplantationof haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003, 361: 553-560. 10.1016/S0140-6736(03)12513-5CrossRefPubMed
9.
go back to reference Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C: Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011, 118: 5108-5118. 10.1182/blood-2011-05-352716CrossRefPubMed Ouederni M, Vincent QB, Frange P, Touzot F, Scerra S, Bejaoui M, Bousfiha A, Levy Y, Lisowska-Grospierre B, Canioni D, Bruneau J, Debré M, Blanche S, Abel L, Casanova JL, Fischer A, Picard C: Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients. Blood. 2011, 118: 5108-5118. 10.1182/blood-2011-05-352716CrossRefPubMed
10.
go back to reference Spelten B, Grussendorf-Conen EI, Rübben A: Human leukocyte antigen class II alleles and natural history of HPV 2/27/57-induced common warts. Arch Dermatol Res. 2004, 296: 105-111.CrossRefPubMed Spelten B, Grussendorf-Conen EI, Rübben A: Human leukocyte antigen class II alleles and natural history of HPV 2/27/57-induced common warts. Arch Dermatol Res. 2004, 296: 105-111.CrossRefPubMed
11.
go back to reference Garcia-Corona C, Vega-Memije E, Barquera R, Granados J: HLA-DR alleles associated with skin warts induced by human papillomavirus infection. Inter J Dermatol. 2010, 49: 1376-1379. 10.1111/j.1365-4632.2010.04599.x.CrossRef Garcia-Corona C, Vega-Memije E, Barquera R, Granados J: HLA-DR alleles associated with skin warts induced by human papillomavirus infection. Inter J Dermatol. 2010, 49: 1376-1379. 10.1111/j.1365-4632.2010.04599.x.CrossRef
12.
go back to reference Shetty K, Chattopadhyay A, Leigh J: Detection and typing of human papilloma virus in the oral mucosa of patients infected with human immunodeficiency virus. Oral Oncology EXTRA. 2005, 41: 311-315. 10.1016/j.ooe.2005.07.011.CrossRef Shetty K, Chattopadhyay A, Leigh J: Detection and typing of human papilloma virus in the oral mucosa of patients infected with human immunodeficiency virus. Oral Oncology EXTRA. 2005, 41: 311-315. 10.1016/j.ooe.2005.07.011.CrossRef
13.
go back to reference Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP: Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001, 91: 62-69. 10.1067/moe.2001.108797CrossRefPubMed Summersgill KF, Smith EM, Levy BT, Allen JM, Haugen TH, Turek LP: Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001, 91: 62-69. 10.1067/moe.2001.108797CrossRefPubMed
14.
go back to reference Draganov P, Mateev G, Botev I, Kalvatchev Z: Identification of multiple human papillomavirus (HPV) genotypes in a patient with oral condylomata acuminata. Biotechnol & Biotechnol Eq. 2006, 20: 107-110.CrossRef Draganov P, Mateev G, Botev I, Kalvatchev Z: Identification of multiple human papillomavirus (HPV) genotypes in a patient with oral condylomata acuminata. Biotechnol & Biotechnol Eq. 2006, 20: 107-110.CrossRef
Metadata
Title
Oral HPV infection and MHC class II deficiency (A study of two cases with atypical outcome)
Authors
Naouel Guirat-Dhouib
Yemen Baccar
Imène Ben Mustapha
Monia Ouederni
Sameh Chouaibi
Nadia El Fekih
Mohamed Ridha Barbouche
Bassima Fezaa
Ridha Kouki
Slama Hmida
Fethi Mellouli
Mohamed Bejaoui
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Clinical and Molecular Allergy / Issue 1/2012
Electronic ISSN: 1476-7961
DOI
https://doi.org/10.1186/1476-7961-10-6

Other articles of this Issue 1/2012

Clinical and Molecular Allergy 1/2012 Go to the issue